- Home
- ARCT
as 05-13-2025 4:00pm EST
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 298.3M | IPO Year: | N/A |
| Target Price: | $57.40 | AVG Volume (30 days): | 410.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.04 - $45.00 | Next Earning Date: | 05-12-2025 |
| Revenue: | $143,680,000 | Revenue Growth: | 15.38% |
| Revenue Growth (this year): | -25.54% | Revenue Growth (next year): | 44.93% |
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
18 hours ago
Q1 2025 Arcturus Therapeutics Holdings Inc Earnings Call
GuruFocus.com
a day ago
Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ...
Zacks
a day ago
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
Associated Press Finance
a day ago
Arcturus Therapeutics: Q1 Earnings Snapshot
Business Wire
a day ago
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
GuruFocus.com
5 days ago
Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Reports Q1 2025 Result
Zacks
9 days ago
Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline
Business Wire
21 days ago
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
Compare ARCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.